Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sue Kyoung Jo"'
Autor:
Tarun Saluja, Bishnu Rath Giri, Shipra Chaudhary, Dipesh Tamrakar, Piush Kanodia, Sonali Palkar, Sridhar Vemula, Suchada Chinaworapong, Bomi Kim, Birendra Prasad Gupta, Sue Kyoung Jo, Sanet Aspinall, Ganesh Kumar Rai, Duncan Steele, Jerome H. Kim, T. Anh Wartel, Sushant Sahastrabuddhe
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 7, Pp 2149-2157 (2021)
Clinical trials are complicated, time-consuming and costly. From the initial screening, informed consent and recruitment of the participants’ to study completion, the sponsor must undertake a wide array of complex and closely monitored operations,
Externí odkaz:
https://doaj.org/article/e12334ef5c8b46b391245a371de2d894
Autor:
Maria Rosario Capeding, Birkneh Tilahun Tadesse, Arijit Sil, Edison Alberto, Deok Ryun Kim, Eun Lyeong Park, Ju Yeon Park, Jae Seung Yang, Jagadeesh Reddy Eluru, Sue-Kyoung Jo, Hun Kim, Seon-Young Yang, Ji Hwa Ryu, Hokeun Park, Jong Hoon Shin, Yoonyeong Lee, Jerome H. Kim, Zenaida Reynoso Mojares, T. Anh Wartel, Sushant Sahastrabuddhe
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-8 (2022)
Abstract Vaccination with typhoid conjugate vaccines (TCV) is a major part of typhoid prevention. However, little is known about long-term immune persistence following vaccination with TCVs. In this phase-2, randomized double-blind trial (NCT03527355
Externí odkaz:
https://doaj.org/article/e37d05b1c20b4f23851267351eb19f82
Autor:
Maria Rosario Capeding, Arijit Sil, Birkneh Tilahun Tadesse, Tarun Saluja, Samuel Teshome, Edison Alberto, Deok Ryun Kim, Eun Lyeong Park, Ju Yeon Park, Jae Seung Yang, Suchada Chinaworapong, Jiwook Park, Sue-Kyoung Jo, Yun Chon, Seon-Young Yang, Ji Hwa Ryu, Inho Cheong, Kyu-Young Shim, Yoonyeong Lee, Hun Kim, Julia A. Lynch, Jerome H. Kim, Jean-Louis Excler, T. Anh Wartel, Sushant Sahastrabuddhe
Publikováno v:
EClinicalMedicine, Vol 27, Iss , Pp 100540- (2020)
Background: Typhoid causes significant mortality among young children in resource-limited settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths, but only one WHO-prequalified typhoid conjugate vaccine exists for
Externí odkaz:
https://doaj.org/article/aced71a85bf64c20b114d96beda3a6aa
Autor:
Ganesh, Kumar Rai, Tarun, Saluja, Shipra, Chaudhary, Dipesh, Tamrakar, Piush, Kanodia, Bishnu Rath, Giri, Rajeev, Shrestha, Surendra, Uranw, Deok Ryun, Kim, Jae Seung, Yang, Il-Yeon, Park, Seung-Eun, Kyung, Sridhar, Vemula, Jagadeesh, Reddy E, Bomi, Kim, Birendra Prasad, Gupta, Sue Kyoung, Jo, Ji Hwa, Ryu, Ho Keun, Park, Jong Hoon, Shin, Yoonyeong, Lee, Hun, Kim, Jerome H, Kim, Zenaida Reynoso, Mojares, T Anh, Wartel, Sushant, Sahastrabuddhe
Publikováno v:
The Lancet Infectious Diseases. 22:529-540
Typhoid fever is an endemic disease in many low-income and middle-income countries. The 2018 WHO position paper recommends that countries should consider typhoid vaccination in high-risk groups and for outbreak control. To address the typhoid vaccine
Autor:
A. Duncan Steele, T. Anh Wartel, Suchada Chinaworapong, Birendra Prasad Gupta, Dipesh Tamrakar, Bomi Kim, Sridhar Vemula, Jerome H. Kim, Bishnu Rath Giri, Shipra Chaudhary, Sushant Sahastrabuddhe, Piush Kanodia, Sanet Aspinall, Sue Kyoung Jo, Ganesh Kumar Rai, Sonali Palkar, Tarun Saluja
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Clinical trials are complicated, time-consuming and costly. From the initial screening, informed consent and recruitment of the participants’ to study completion, the sponsor must undertake a wide array of complex and closely monitored operations,
Autor:
Sue-Kyoung Jo, Seon-Young Yang, Suchada Chinaworapong, Jiwook Park, Dong Soo Ham, Edison Alberto, Sushant Sahastrabuddhe, Jean-Louis Excler, Arijit Sil, Yun Chon, Maria Rosario Capeding, Ju Yeon Park, Jerome H. Kim, T. Anh Wartel, Julia Lynch, Deok Ryun Kim, Jae Seung Yang, Samuel Teshome, Ji Hwa Ryu, Tarun Saluja, Hun Kim
Publikováno v:
Vaccine
Highlights • Vi-DT is safe and well tolerated in infants and toddlers aged 6–23 months. • Vi-DT showed >1000-fold higher Geometric Mean Titer (GMT) compared to Placebo. • 100% seroconversion reported in Vi-DT group in all age strata.
Bac
Bac
Autor:
Tarun Saluja, Ganesh Kumar Rai, Shipra Chaudhary, Piush Kanodia, Bishnu Rath Giri, Deok Ryun Kim, Jae Seung Yang, Il-Yeon Park, Seung-Eun Kyung, Sridhar Vemula, Jagadeesh Reddy E, Bomi Kim, Birendra Prasad Gupta, Sue Kyoung Jo, Ji Hwa Ryu, Ho Keun Park, Jong Hoon Shin, Yoonyeong Lee, Hun Kim, Jerome H. Kim, Zenaida Reynoso Mojares, T. Anh Wartel, Sushant Sahastrabuddhe
Publikováno v:
Vaccine. 40(40)
Typhoid fever is a common disease in developing countries especially in the Indian subcontinent and Africa. The available typhoid conjugate vaccines (TCV) have been found to be highly immunogenic in infants and children less than 2 years of age. Many
Autor:
Suchada Chinaworapong, Seon-Young Yang, T. Anh Wartel, Arijit Sil, Deok Ryun Kim, Jerome H. Kim, Eun Lyeong Park, Jae Seung Yang, Sushant Sahastrabuddhe, Kyu-Young Shim, Yoonyeong Lee, Edison Alberto, Ji Hwa Ryu, Sue-Kyoung Jo, Birkneh Tilahun Tadesse, Julia Lynch, Ju Yeon Park, Tarun Saluja, Hun Kim, Maria Rosario Capeding, Inho Cheong, Jiwook Park, Jean-Louis Excler, Yun Chon, Samuel Teshome
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 27, Iss, Pp 100540-(2020)
EClinicalMedicine, Vol 27, Iss, Pp 100540-(2020)
Background: Typhoid causes significant mortality among young children in resource-limited settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths, but only one WHO-prequalified typhoid conjugate vaccine exists for
Autor:
Maria Rosario, Capeding, Samuel, Teshome, Tarun, Saluja, Khalid Ali, Syed, Deok Ryun, Kim, Ju Yeon, Park, Jae Seung, Yang, Yang Hee, Kim, Jiwook, Park, Sue-Kyoung, Jo, Yun, Chon, Sudeep, Kothari, Seon-Young, Yang, Dong Soo, Ham, Ji Hwa, Ryu, Hee-Seong, Hwang, Ju-Hwan, Mun, Julia A, Lynch, Jerome H, Kim, Hun, Kim, Jean-Louis, Excler, Sushant, Sahastrabuddhe
Publikováno v:
Vaccine. 36(26)
Typhoid fever remains a major public health problem in low- and middle-income countries where children aged 2-14 years bear the greatest burden. Vi polysaccharide is poorly immunogenic in children2 years of age, and protection in adults is modest. Th